StockStory.org on MSN12 小时
Why Myriad Genetics (MYGN) Shares Are Plunging Today
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 16.1% in the morning session after the ...
Zacks.com on MSN18 小时
MYGN Q4 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down
Myriad Genetics, Inc. MYGN reported fourth-quarter 2024 adjusted earnings of 3 cents per share, which came in line with the ...
EurekAlert!3 天
Award-winning pharmaco-geneticist advances drug discovery and development for Africans
Masimirembwa, a Distinguished Professor at Wits University's Sydney Brenner Institute for Molecular Bioscience (SBIMB), ...
U.S. Pharmacogenomics Market Size Predicted To Hit USD 5,676.1 Million By 2031 At 8.7% CAGR ...
U.S. Pharmacogenomics Market Growth 2025 Pharmacogenomics, also known as pharmacogenetics, is a branch of genomic medicine that uses a pati ...
Daily5 天
Survey Reveals 90 Percent Support for Genetic Testing to Personalize Medication Use
The key findings from the survey stated that only half of participants knew that variations in DNA can predict either ...
NetNewsLedger5 天
Canadian Pharmacist Abadir Nasr Speaks on the Rise of Personalized Medicine in Canada
Canada’s pharmaceutical industry is undergoing a major transition towards personalized medicine, which customizes therapies ...
News Medical5 天
Survey reveals public enthusiasm for personalizing medicine with genetic data
Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised healthcare but little is known about the public's views on it.
Armed robbery in Revesby5 天
Survey: 90% Open to Genetic Testing for Med Tailoring
Biochemist working with microscope Pharmacogenomics – an individual's genetic response to medications – is an increasingly ...
Armed robbery in Revesby6 天
Survey: 90% Open to Genetic Testing for Meds
Pharmacogenomics – an individual's genetic response to medications – is an increasingly important strand of personalised ...